Congenital immunodeficiency disorders

Congenital immunodeficiency disorders are characterized by a deficiency, absence, or defect in one or more of the main components of the immune system. These disorders are genetically determined and typically manifest during infancy and childhood as frequent, chronic, or opportunistic infections. Classification is based on the component of the immune system that is deficient, absent, or defective. The diagnosis is confirmed with tests such as differential WBC count, absolute lymphocyte count, quantitative immunoglobulin (Ig) measurements, and antibody titers. Treatment usually consists of prophylactic antibiotics to manage and prevent infections. The prognosis in congenital immunodeficiency disorders is variable and depends on the specific disorder.

Congenital B-cell immunodeficiencies

Congenital T-cell immunodeficiencies

Congenital combined immunodeficiencies

Congenital neutrophil and phagocyte disorders

Complement disorders

B-cell defects (humoral immunity deficiencies) account for 50–60% of all primary immunodeficiencies.

Bruton agammaglobulinemia (X-linked agammaglobulinemia) ^[3]

• Definition: X-linked recessive; disease that causes a complete deficiency of mature B lymphocytes
• Epidemiology: occurs mainly in boys
• Etiology: defect of Bruton tyrosine kinase (BTK) expressed in B cells → complete deficiency of mature B cells
• Clinical features: Symptoms develop between 3 and 6 months of age when maternal IgG levels in fetal serum start to decrease.
  • Hypoplasia of lymphoid tissue (e.g., tonsils, lymph nodes)
  • Recurrent, severe, pyogenic infections (e.g., pneumonia, otitis media), especially with encapsulated bacteria (S. pneumoniae, N. meningitidis, and H. influenzae)
  • Hepatitis virus and enterovirus (e.g., Coxsackie virus) infections
• Diagnosis
  • Flow cytometry
    • Absent or low levels of B cells (marked by CD19, CD20, and CD21)
    • Normal or high T cells
  • Low immunoglobulins of all classes
  • Absent lymphoid tissue, i.e., no germinal centers and primary follicles
• Treatment
  • IV immunoglobulins
  • Prophylactic antibiotics

Live vaccines (e.g., MMR) are contraindicated in patients with Bruton agammaglobulinemia.

Bruton agammaglobulinemia: Brutal defects in a B cell make little Boys feel unwell.

Selective IgA deficiency (SIgAD) ^[4][5]

• Definition: most common primary immunodeficiency; that is characterized by a near or total absence of serum and secretory IgA
• Epidemiology: approx. 1:220 to 1:1,000
• Etiology: unknown
• Clinical features
  • Often asymptomatic
  • May manifest with sinusitis or respiratory infections (S. pneumoniae, H. influenzae)
  • Chronic diarrhea, partially due to elevated susceptibility to parasitic infection; (e.g. by Giardia lamblia)
  • Associated with autoimmune diseases (e.g., gluten-sensitive enteropathy, inflammatory bowel disease, immune thrombocytopenia) and atopy
  • Anaphylactic reaction to products containing IgA (e.g., intravenous immunoglobulin)
• Diagnosis
  • Decreased serum IgA levels (< 7 mg/dL)
  • Normal IgG and IgM levels
  • False-positive pregnancy tests ^[6]
• Treatment
  • Treatment of infections
  • Prophylactic antibiotics
  • Intravenous infusion of IgA is not recommended because of the risk of anaphylactic reactions (caused by the production of anti-IgA antibodies).

To prevent transfusion reactions, IgA-deficient patients must be given washed blood products without IgA or obtain blood from an IgA-deficient donor.

The Six A's of selective IgA deficiency: Asymptomatic, Airway infections, Anaphylaxis to IgA-containing products, Autoimmune diseases, Atopy

Common variable immunodeficiency (CVID) ^[7][8][9]

• Definition: primary immunodeficiency with low serum levels of all immunoglobulins despite phenotypically normal B cells
• Epidemiology
  • Sex: ♀ = ♂
  • Onset: later than other B-cell defects (typically at 20–40 years of age) ^[10]
• Etiology: Most cases are sporadic with no known family history.
• Pathophysiology: B cells are phenotypically normal but are unable to differentiate into Ig-producing cells, resulting in low immunoglobulins of all classes.
• Clinical features
  • Recurrent pyogenic respiratory infections, e.g., sinopulmonary infections (in rare cases, enteroviral meningitis)
  • Associated with a high risk of lymphoma, gastric cancer, bronchiectasis, and autoimmune disorders (e.g., rheumatoid arthritis, autoimmune hemolytic anemia, immune thrombocytopenia, vitiligo) ^[11]
• Diagnosis
  • Quantitative immunoglobulin levels: low levels of IgG, IgA, and IgM
  • Decreased number of plasma cells
  • Flow cytometry shows subsets of normal B and T cells
  • Poor response to immunizations
• Treatment
  • Treatment of infections
  • Prophylactic antibiotics
  • IV immunoglobulins

T-cell defects (cellular immunity deficiencies) are responsible for 5–10% of congenital immunodeficiencies.

DiGeorge syndrome (22q11.2 deletion syndrome) ^[12]

• Definition: : syndrome characterized by defective development of the third and fourth pharyngeal pouches leading to hypoplastic thymus and parathyroids
• Etiology: autosomal dominant; microdeletion at chromosome 22 (22q11.2)
• Clinical features
  • Cardiac anomalies
    • Conotruncal abnormalities (e.g., tetralogy of Fallot or persistent truncus arteriosus)
    • Ventricular septal defect (VSD)
    • Atrial septal defect (ASD)
  • Anomalous face
    • Prominent nasal bridge
    • Hypoplastic wing of the nose
    • Dysplastic ears
    • Micrognathia; (small lower jaw) and/or retrognathia
  • Thymus aplasia/hypoplasia: recurrent infections (viral/fungal/PCP pneumonia) due to T-cell deficiency
  • Cleft palate
  • Hypoparathyroidism: hypocalcemia with tetany
• Diagnosis
  • Detection of 22q11.2 deletion via fluorescence in situ hybridization (FISH)
  • ↓ PTH and Ca²⁺
  • ↓ Absolute T-lymphocyte count
  • Delayed hypersensitivity skin testing
  • CXR: absence of thymic shadow
• Treatment
  • Immune deficiency treatment
    • Antibiotics, virostatics, and antimycotics
    • PCP prophylaxis
    • Consider bone marrow transplant and/or IVIG
  • Possible thymus transplantation
• Prognosis: poor if not treated (patients usually do not survive beyond childhood)

CATCH-22 is the acronym for typical features of DiGeorge syndrome: Cardiac anomalies; Anomalous face; Thymic aplasia/hypoplasia; Cleft palate; Hypocalcemia; Chromosome 22.

Autosomal dominant hyperimmunoglobulin E syndrome (Job syndrome) ^[13]

• Definition: defect in neutrophil chemotaxis
• Etiology: autosomal dominant; STAT3 mutation → ↓ Th17 cells → ↓ neutrophil/macrophage chemotaxis
• Clinical features
  • Coarse Facies
  • Noninflamed Abscesses, recurrent bacterial (staphylococcal) infections
  • Retained primary Teeth
  • Hyper-IgE (Eosinophilia)
  • Dermatologic (severe eczema)
  • Other features: Decreased bone density increases the risk of bone fractures following minor trauma. ^[14]
• Diagnosis
  • ↑ IgE
  • (Variable) eosinophilia
  • ↓ IFN γ
  Treatment
  • Antibiotics and prophylaxis (with penicillinase-resistant antibiotics)
  • IV immunoglobulin therapy

FATED is the acronym for the typical features of Autosomal dominant hyper-IgE syndrome: Coarse Facies/Fractures; Abscesses; Retained primary Teeth; Hyper-IgE/Eosinophilia); Dermatologic (severe eczema).

IL-12 receptor deficiency ^[15][16][17]

• Definition: impaired Th1 response due to ↓ IL-12 receptors
• Etiology: autosomal recessive
• Pathophysiology
  • Normally, antigen-presenting macrophages release IL-12 → Th cells transformation to T1 type → release of IFN-γ to activate macrophages
  • Defective IL-12 receptors: macrophages cannot be activated by IFN-γ → no cytotoxicity in cells infected with intracellular pathogens (e.g., Mycobacteria, Salmonella)
  • IL-12 receptor deficiency is the underlying pathology in most cases of high Mendelian susceptibility to mycobacterial disease (MSMD)
• Clinical features
  • The age of onset varies (depends on the age at exposure to causative pathogens): ∼ 1–3 years of age
  • Features of disseminated disease
    • Mycobacterial infections (e.g., developing tuberculosis after BCG vaccination)
    • Fungal infections
• Diagnosis: : ↓ IFN-γ
• Treatment: antibiotics and IFN-γ therapy

Chronic mucocutaneous candidiasis

• Definition: impaired or absent T-cell response to Candida antigens
• Etiology
  • Several congenital defects that result in impaired T-cell function
  • Autoimmune regulator (AIRE protein) deficiency is a common cause.
  • The majority of cases are caused by a gain of function mutation in the STAT1 gene. ^[18]
• Pathophysiology: defects in IL-17 and IL-17 receptors → insufficient cell-mediated immune response to Candida infections
• Clinical features
  • Persistent or, less commonly, recurrent noninvasive Candida infections of the skin, mucous membranes, and nails
  • Associated autoimmune disorders (e.g., immune thrombocytopenic purpura, rheumatoid arthritis)
• Diagnosis
  • Usually clinical
  • Absent in vitro T-cell proliferation when exposed to Candida antigen
  • Absent cutaneous reaction to Candida antigen
• Treatment
  • Antifungal therapy
  • Treatment of associated conditions

IPEX syndrome (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked)

• Definition: : A syndrome characterized by a dysfunctional regulatory T-cell lineage that leads to autoimmunity as a result of disrupted tolerance to self-antigens.
• Etiology
  • X-linked recessive type of inheritance
  • Mutation in transcription factor FOXP3 → unchecked activation of T cells against host tissues
• Clinical features
  • Classically presents in early infancy
  • Lymphadenopathy and/or chronic lymphoid tissue hypertrophy (e.g., enlarged tonsils)
  • Eczema, possibly accompanied by other autoimmune dermatologic conditions
  • Autoimmune endocrine conditions (e.g., hyperthyroidism or hypothyroidism, type 1 diabetes mellitus in male individuals)
  • Enteropathy, manifesting as e.g., chronic diarrhea
  • Nail dystrophy
  • Failure to thrive
• Diagnosis
  • Primarily based on clinical examination and family history
  • Genetic testing: mutations in FOXP3
  • Flow cytometry: severely reduced or absent CD4+CD25+ regulatory T cells with otherwise normal T-cell populations
• Treatment
  • Nutritional support
  • Immunosuppression: tacrolimus, cyclosporine, or sirolimus
  • Rituximab
  • Bone marrow transplant

Severe combined immunodeficiency (SCID, Glanzmann–Riniker syndrome, alymphocytosis)

• Definition: : A rare genetic condition caused by numerous genetic mutations that result in the defective development of functional B cells and T cells.
• Etiology: various mutations, the most common of which are:
  • X-linked recessive: mutations in the gene encoding the common gamma chain → defective IL-2R gamma chain receptor linked to JAK3 (most common SCID mutation)
  • Autosomal recessive
    • Adenosine deaminase (ADA) deficiency → accumulation of toxic metabolites (deoxyadenosine and dATP) and disrupted purine metabolism → accumulation of dATP inhibits the function of ribonucleotide reductase → impaired generation of deoxynucleotides
    • Janus-associated kinase 3 (JAK3) deficiency
  • RAG mutation results in faulty VDJ recombination (see “Immunoglobulin properties”).
• Clinical features
  • Normal at birth
  • Severe, recurrent infections: bacterial diarrhea, chronic candidiasis (thrush), viral and protozoal infections
  • Failure to thrive
  • Chronic diarrhea
  • Lymph nodes and tonsils may be absent
• Subtype
  • Omenn syndrome: an autosomal recessive form of SCID ^[19]
    • Etiology: mutations of RAG gene or ILRA7 gene
    • Clinical features
      • Onset before 3 months of age
      • Erythroderma, adenopathy, and hepatosplenomegaly
      • Severe, recurrent infections
      • Failure to thrive
    • Diagnosis: oligoclonal T cells, eosinophilia, ↑ IgE levels
• Diagnosis
  • Quantitative PCR: ↓ T-cell receptor excision circles (TRECs); detection of TRECs is used in the newborn screening for SCID
  • Flow cytometry: absent T cells
  • CXR: absent thymic shadow
  • Lymph node biopsy: absent germinal centers
• Treatment
  • IV immunoglobulins
  • PCP prophylaxis
  • Bone marrow transplant or stem cell transplantation
  • Avoidance of live vaccines
  • Prognosis: often fatal in the first year of life if left untreated ^[20]

Wiskott-Aldrich syndrome (WAS)

• Definition: genetic condition characterized by impaired function of T cells and thrombocytopenia
• Epidemiology: : occurs primarily in males
• Etiology: mutated WASp gene (X-linked recessive inheritance) → impaired signaling to actin cytoskeleton reorganization → defective antigen presentation
• Clinical features
  • Onset of symptoms: from birth
  • Classic triad
    • Purpura (bleeding diathesis)
    • Eczema (high risk of atopic disorders)
    • Recurrent opportunistic infections with encapsulated organisms; in the first years of life (e.g., otitis media)
  • Increased risk of autoimmune diseases and hematological malignancies (e.g., lymphoma, leukemia)
• Diagnosis
  • Normal or ↓ IgG and IgM
  • ↑ IgE and IgA
  • Thrombocytopenia with small platelets
  • Genetic analysis (confirmatory test): mutated WASp gene
• Treatment
  • IV immunoglobulin therapy
  • Prophylactic antibiotics
  • Platelet transfusions
  • Stem cell transplantation may be curative.
• Prognosis: : shortened life expectancy

Classic findings of Wiskott-Aldrich syndrome (Wiskott-Aldrich syndrome, Purpura, Eczema, Recurrent infections): WisPER

Hyper-IgM syndrome ^[21]

• Definition: A group of syndromes characterized by impaired interaction between Th cells and B cells that results in a B cell class-switching defect
• Epidemiology: CD40 ligand deficiency is the most common form.
• Etiology
  • X-linked recessive inheritance
  • CD40L deficiency in Th cells leads to abnormal interaction with B cells that express the CD40 receptor, disrupting B-cell class-switching, which leads to depleted immunoglobulins
• Clinical features
  • Recurrent severe pyogenic infections that manifest since childhood
    • Opportunistic sinopulmonary infections (commonly Pneumocystis jirovecii and Histoplasma)
    • Cryptosporidium enteritis (which may lead to biliary disease, cirrhosis, and cholangiocarcinoma)
    • CMV hepatitis
  • Failure to thrive
• Diagnosis
  • ↓ IgG, IgA, IgE
  • Normal or ↑ IgM
  • Lymph node biopsy: absent germinal centers
• Treatment
  • IV immunoglobulin therapy
  • Prophylactic antibiotics
  • Recombinant human granulocyte-colony stimulating factor
  • Stem cell transplantation may be curative.

Ataxia telangiectasia

• See “Ataxia telangiectasia” for details.

Phagocytic defects are characterized by the impaired ability of phagocytic cells (e.g., monocytes, macrophages, granulocytes such as neutrophils and eosinophils) to kill pathogens. These types of defects account for 10–15% of primary immunodeficiencies.

Chronic granulomatous disease (CGD)

• Definition: deficiency of superoxide production by polymorphonuclear neutrophils and macrophages
• Etiology
  • X-linked recessive or autosomal recessive inheritance (2:1)
  • Defective phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase that results in:
    • Defective reactive oxygen species (ROS) production (e.g., superoxide) → impaired ability to deactivate or kill ingested microorganisms
    • Decreased respiratory burst in neutrophils
• Clinical features
  • Recurrent, severe infections (chronic skin, lymph node, bone, respiratory, GI, and urinary tract infections) with catalase-positive organisms; (S. aureus; , Nocardia spp., Escherichia coli, Candida, Klebsiella, Pseudomonas, Aspergillus, Serratia)
  • Lymphadenopathy
  • Granulomas of the skin and GI/GU tract
• Diagnosis
  • Neutrophil assay
    • Dihydrorhodamine test (DHR): flow cytometry test showing abnormal NADPH oxidase activity; (inability to metabolize dihydrorhodamine to fluorescent product, rhodamine → decreased green fluorescence) ^[22]
    • Nitroblue tetrazolium dye reduction test: negative, i.e., incubated leukocytes fail to turn blue when exposed to nitroblue tetrazolium
  • Hypergammaglobulinemia
  • Anemia
  • Genotyping is confirmatory
• Treatment
  • Treatment of infections
  • Life-long prophylactic antibiotics, e.g., TMP-SMX (for catalase-positive infections)
  • Antifungal prophylaxis (e.g., itraconazole, voriconazole, posaconazole)
  • Glucocorticoids for severe inflammation
  • IFN-γ therapy
  • Bone marrow transplant
  • Possibly gene therapy

Leukocyte adhesion deficiency type 1 (LAD1)

• Definition: : A genetic condition characterized by a defect in the leukocytic chemotaxis that results in decreased phagocyte activity
• Etiology
  • Autosomal recessive inheritance
  • Absence of the β2-integrin leukocyte adhesion surface molecule LFA-1 (CD18) prevents leukocytes from migrating to tissues during infection or inflammation.
• Clinical features
  • Recurrent nonsuppurative bacterial infections (e.g., skin and mucosal infections) with minimal inflammation due to dysfunctional neutrophils
  • Impaired wound healing
  • Omphalitis
  • Delayed separation of the umbilical cord (> 2 weeks postpartum)
• Diagnosis
  • Leukocytosis; however, neutrophils are absent at the site of infection
  • Flow cytometry: absent CD18, CD11a, CD11b, and CD11c
• Treatment
  • Prevention of further infections (e.g., adequate dental hygiene)
  • Treatment of infections
  • Bone marrow transplant

Chédiak-Higashi syndrome

• Definition: defect in neutrophil chemotaxis and microtubule polymerization dysfunction → defective phagosome-lysosome fusion
• Etiology: autosomal recessive; defective lysosomal trafficking regulator (LYST) gene
• Clinical features
  • Recurrent pyogenic infections
    • May be extensive if massive infiltration occurs
    • Pathogens include: S. pyogenes, S. aureus, and Pseudomonas spp.
  • Partial albinism
  • Progressive degeneration of neurons and peripheral neuropathy
  • Hemophagocytic lymphohistiocytosis (can occur in the accelerated phase and is potentially fatal)
• Diagnosis
  • Peripheral smear shows giant cytoplasmic granules in granulocytes and platelets
  • Mild coagulation abnormalities
  • Pancytopenia (especially neutropenia)
• Treatment: bone marrow transplant

Classic findings of Chediak-Higashi syndrome (Albinism, Lymphohistiocytosis, Peripheral neuropathy, Infections, Neurodegeneration, Neutropenia): ALPINe

Myeloperoxidase deficiency

• Definition: : A genetic condition characterized by the deficiency or absence of myeloperoxidase enzyme in phagocytes that are unable to form hypochlorous acid (HClO) but have preserved respiratory burst (since NADPH oxidase is intact).
• Etiology: autosomal recessive mutation in the MPO gene
• Clinical features
  • Recurrent Candida infections (e.g., oral thrush, vulvovaginitis)
  • Many patients are asymptomatic.
• Diagnosis
  • Positive nitroblue tetrazolium test: intact NADPH oxidase
  • Absent myeloperoxidase on staining
  • Mutations in MPO gene on sequencing
• Treatment
  • No specific treatment or prophylaxis
  • Treatment of fungal infections

Severe congenital neutropenia

• Definition: A deficiency of neutrophils that occurs at or around birth due to bone marrow failure of the myeloid lineage.
• Etiology
  • Autosomal dominant, autosomal recessive, or X-linked recessive inheritance
  • Mutations in the neutrophil elastase gene, HAX1 gene, and Wiskott-Aldrich syndrome gene
• Clinical features
  • Recurrent bacterial infections, e.g., gingivitis, otitis media, respiratory infections, and cellulitis due to Streptococcus and Staphylococcus
  • Oral ulcerations are commonly seen by the age of 2 years.
• Diagnosis
  • Absolute neutropenia with relative monocytosis. Absolute neutrophil count is usually < 200/microL in infants.
  • Bone marrow examination
    • Normal or decreased cellularity
    • Arrest of the myeloid lineage at the promyelocyte/myelocyte stage
• Treatment
  • G-CSF
  • Hematopoietic cell transplantation

Complement deficiencies are rare (≤ 2%) deficiencies of complement components or inhibitors.

C1 esterase inhibitor deficiency (hereditary angioedema)

• See “Bradykinin-mediated angioedema.”

Terminal complement deficiency (C5–C9 deficiency)

• Definition: impaired formation of the membrane attack complex due to deficiencies in terminal complement factors (C5–C9)
• Epidemiology: C5, C6, and C8 deficiency are the most common
• Etiology: autosomal recessive pattern
• Clinical features
  • Recurrent pyogenic infections (e.g., meningococcal or gonococcal)
  • Associated with SLE and glomerulonephritis
  • Life-threatening sepsis may occur in prolonged disease.
• Diagnosis: CH50 assay screening test
• Treatment
  • Meningococcal vaccine
  • Prophylactic antibiotics

C3 deficiency ^[23]

• Definition: deficiency of the complement factor C3 and its cleaved fragments (e.g., C3b)
• Etiology: primary or secondary due to impairment in the regulatory proteins factor I or factor H
• Pathophysiology: decreased levels of the opsonin C3b → impaired opsonization of pathogens by the innate immune system and reduced clearance of C3b-bound immune complexes
• Clinical features
  • Recurrent, severe, childhood infections (e.g., upper respiratory tract infections, pneumonia, meningitis) with encapsulated bacteria (e.g., N. meningitidis, H. influenzae, S. pneumoniae)
  • Associated with autoimmune diseases (e.g., SLE) and type III hypersensitivity reactions

1. Fomin AB, Pastorino AC, Kim CA, Pereira C, Carneiro-Sampaio M, Abe-Jacob CM. DiGeorge Syndrome: a not so rare disease. Clinics. 2010; 65 (9): p.865-869. doi: 10.1590/s1807-59322010000900009 . | Open in Read by QxMD
2. Khan K, Wozniak SE, Giannone AL, Abdulmassih ME. A boy with relentless pruritus: Job’s Syndrome. Am J Case Rep. 2016; 17 : p.104-110. doi: 10.12659/ajcr.896798 . | Open in Read by QxMD
3. Wissem Hafsi, Talel Badri. Job Syndrome (Hyperimmunoglobulin E). StatPearls Publishing. 2019 .
4. Caragol I, Casanova JL. Inherited disorders of the Interleukin-12/ Interferon-gamma axis: Mendelian predisposition to mycobacterial disease in man. Inmunología. 2003; 22 (3): p.263-276.
5. Palamaro L, Giardino G, Santamaria F et al . Interleukin 12 receptor deficiency in a child with recurrent bronchopneumonia and very high IgE levels. Ital J Pediatr. 2012; 38 (46). doi: 10.1186/1824-7288-38-46 . | Open in Read by QxMD
6. Prando C, Samarina A, Bustamante J et al. . Inherited IL-12p40 deficiency. Medicine (Baltimore). 2013; 92 (2): p.109-122. doi: 10.1097/MD.0b013e31828a01f9 . | Open in Read by QxMD
7. Okada S, Puel A, Casanova J-L, Kobayashi M. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Clin Transl Immunology.. 2016; 5 (12): p.e114. doi: 10.1038/cti.2016.71 . | Open in Read by QxMD
8. Omenn syndrome. https://rarediseases.info.nih.gov/diseases/8198/omenn-syndrome/cases/34404#:~:text=Infants%20with%20Omenn%20syndrome%20typically,precede%20the%20onset%20of%20infections.. Updated: March 21, 2012. Accessed: February 24, 2021.
9. Mary Dell Railey, M.D., Yuliya Lokhnygina, Ph.D., and Rebecca H. Buckley, M.D.. Long Term Clinical Outcome of Patients with Severe Combined Immunodeficiency who Received Related Donor Bone Marrow Transplants without Pre-transplant Chemotherapy or Post-transplant GVHD Prophylaxis. The Journal of Pediatrics. 2009 .
10. X-Linked Hyper IgM Syndrome.
11. Dihydrorhodamine (DHR) Flow Cytometric Phorbol Myristate Acetate (PMA) Test, Blood. https://www.mayomedicallaboratories.com/test-catalog/Overview/62765. Updated: January 1, 2018. Accessed: July 19, 2018.
12. Greenberg DE, Goldberg JB, Stock F, Murray PR, Holland SM, LiPuma JJ. RecurrentBurkholderiaInfection in Patients with Chronic Granulomatous Disease: 11‐Year Experience at a Large Referral Center. Clinical Infectious Diseases. 2009; 48 (11): p.1577-1579. doi: 10.1086/598937 . | Open in Read by QxMD
13. Macedo ACL, Isaac L. Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway. Frontiers in Immunology. 2016; 7 . doi: 10.3389/fimmu.2016.00055 . | Open in Read by QxMD
14. S. Reis E, Falcao DA, Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol. 2006; 63 (3): p.155-168. doi: 10.1111/j.1365-3083.2006.01729.x . | Open in Read by QxMD
15. Bruton Agammaglobulinemia.
16. Yel L . Selective IgA deficiency. J Clin Immunol. 2010; 30 (1): p.1-16. doi: 10.1007/s10875-009-9357-x . | Open in Read by QxMD
17. Selective IgA Deficiency. http://www.msdmanuals.com/professional/immunology-allergic-disorders/immunodeficiency-disorders/selective-iga-deficiency. Updated: August 1, 2016. Accessed: May 15, 2017.
18. Cole LA. False Positive hCG Assays. Elsevier ; 2010 : p. 229-236
19. Common Variable Immune Deficiency. https://rarediseases.org/rare-diseases/common-variable-immune-deficiency/. Updated: January 1, 2017. Accessed: April 17, 2020.
20. Sneller MC. New insights into common variable immunodeficiency. Ann Intern Med. 1993; 118 (9): p.720. doi: 10.7326/0003-4819-118-9-199305010-00011 . | Open in Read by QxMD
21. Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program. 2012; 2012 : p.301-305.
22. Tam JS, Routes JM. Common Variable Immunodeficiency. American Journal of Rhinology & Allergy. 2013; 27 (4): p.260-265. doi: 10.2500/ajra.2013.27.3899 . | Open in Read by QxMD
23. Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Ann Allergy Asthma Immunol. 2019; 123 (5): p.454-460. doi: 10.1016/j.anai.2019.07.014 . | Open in Read by QxMD